Recall of Device Recall SeedNet Cryosurgiclal system

According to U.S. Food and Drug Administration, this recall involved a device in United States that was produced by Galil Medical, Inc..

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    57571
  • Event Risk Class
    Class 2
  • Event Number
    Z-1032-2011
  • Event Initiated Date
    2010-12-20
  • Event Date Posted
    2011-02-03
  • Event Status
    Terminated
  • Event Country
  • Event Terminated Date
    2012-03-27
  • Event Source
    USFDA
  • Event Source URL
  • Notes / Alerts
    U.S. data is current through June 2018. All of the data comes from the U.S. Food and Drug Administration, except for the category Manufacturer Parent Company.
    The Parent Company was added by ICIJ.
    The parent company information is based on 2017 public records.
  • Extra notes in the data
    Unit, cryosurgical, accessories - Product Code GEH
  • Reason
    This voluntary correction has been initiated due to the discovery of a damaged optocoupler on one of our presice systems during periodic preventive maintenance. the optocoupler sends a signal across the locking mechanism in the presice and seednet mri systems, enabling the software to recognize if the channel on the system manifold is locked or unlocked. if an optocoupler is damaged or malfunction.
  • Action
    Galil Medical sent an "Urgent Medical Device Correction" letter dated December, 30, 2010, to all affected consignees. The letter described the product, the problem involved, and the action to be taken by the consignee. Consignees were instructed to make sure the locking mechanism on the Precise and Seednet MRI Systems were in the "locked" position when a needle is inserted into the manifold. Gently pull on the black plug to ensure needle is secure in locking mechanism. Apply the enclosed alert sticker on the bottom of the distribution panel and the bottom of the system monitor of the Precise System and on the side of the mobile unit itnerface panel and the top of the system monitor of the Seednet MRI System. Consignees were asked to take a picture of the alert sticker after it has been applied to the appropriate location on their Presice or Seednet MRI System(s) and e-mail to yoni.kadosh@galilmedical.com. Consignees were instructed to complete and return the enclosed form as soon as possible. For questions regarding this recall call Customer Service at (877) 639-2796. problem involved.

Device

  • Model / Serial
    PRCH2035 MA0674 MA0598 MA0479 MA0698 MA0243 MA0332 MA0695 MA0716 MA0736  PRCH2048 MA0665 MA0664 MA0682 MA0686 MA0688 MA0690 MA0689 MA0687 MA0692 MA0694 MA0693 MA0713 MA0342 MA0719
  • Product Classification
  • Device Class
    2
  • Implanted device?
    No
  • Distribution
    Worldwide Distribution - USA including CA, CT, FL, GA, MA, MD, MN, MO, NC, NY, OH, PA, SC, TN, TX, VA, and WA and the countries of CANADA, DENMARK, FINLAND, FRANCE, GERMANY, HONG KONG, ISRAEL, ITALY, KOREA, NETHERLANDS, SPAIN, SWEDEN, TAIWAN, TURKEY, UNITED KINGDOM, CHINA, and JAPAN.CANADA, DENMARK, FINLAND, FRANCE, GERMANY, HONG KONG, ISRAEL, ITALY, KOREA, NETHERLANDS, SPAIN, SWEDEN, TAIWAN, TURKEY, UNITED KINGDOM, CHINA, JAPAN.
  • Product Description
    SeedNet MRI Cryosurgical System, model FPRCH2035, and the following system is not approved in the US: CryoHit MRI Cryoblation System, model FPRCH2048. The system is a software controlled cryoblation system designed to destroy targeted tissue using a minimally invasive percutaneous approach. Freezing and thawing of the tissue is achieved through the use of the Joule-Thompson effect, using a high-pressure gas distributed through closed-end needles placed into the patient;s target organ. || The SeedNet System is intended for cryogenic destruction of tissue during surgical procedures. The modified SeedNet is indicated for use as a cryosurgical tool in the fields of general surgery, dermatology, neurology (including cryoanalgesia), thoracic surgery, ENT, gynecology, oncology, proctology, and urology. The system is designed to destroy tissue by the application of extreme cold temperatures including prostate and kidney tissue, liver metastases, tumors, skin lesions, and warts. The modified SeedNet has the following specific indications: - Urology (ablation of prostate tissue in cases of prostate cancer and Benign Prostate Hyperplasia BPH); - Oncology (ablation of cancerous or malignant tissue and benign tumors, and palliative intervention); - Dermatology (ablation or freezing of skin cancers and other cutaneous disorders. Destruction of warts or lesions, angiomas, sebaceous hyperplasia, basal cell tumors of the eyelid or canthus area, ulcerated basal cell tumors, dermatofibromas small hemanglomas, mucocele cysts, multiple warts, plantar warts, actinic and seborrheic keratoses, cavernous hemanglomas, perianal condylomata, and palliation of tumors of the skin); - Gynecology (ablation of malignant neoplasia or benign dysplasia of the female genitalia); - General surgery (palliation of tumors of the rectum, hemorrhoids, anal fissures, pilonidal cysts, and recurrent cancerous lesions.); - ENT (Palliation of tumors of the oral cavity and ablation of leukoplakia of the mouth); - Thoracic surgery (ablation of arrhythmic cardiac tissue cancerous lesions); - Proctology (ablation of benign or malignant growths of the anus or rectum, and hemorrhoids). The Modified SeedNet System may be used with a magnetic resonance imaging (MRI) device or an ultrasound device to provide real-time visualization of the cryosurgical procedure.
  • Manufacturer

Manufacturer

  • Manufacturer Address
    Galil Medical, Inc., 4364 Round Lake Rd W, Arden Hills MN 55112
  • Manufacturer Parent Company (2017)
  • Source
    USFDA